Form 8-K - Current report:
SEC Accession No. 0001558370-25-001158
Filing Date
2025-02-19
Accepted
2025-02-19 16:45:32
Documents
14
Period of Report
2025-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pmn-20250214x8k.htm   iXBRL 8-K 30962
  Complete submission text file 0001558370-25-001158.txt   166357

Data Files

Seq Description Document Type Size
2 EX-101.SCH pmn-20250214.xsd EX-101.SCH 4047
3 EX-101.DEF pmn-20250214_def.xml EX-101.DEF 2871
4 EX-101.LAB pmn-20250214_lab.xml EX-101.LAB 18534
5 EX-101.PRE pmn-20250214_pre.xml EX-101.PRE 12277
16 EXTRACTED XBRL INSTANCE DOCUMENT pmn-20250214x8k_htm.xml XML 5217
Mailing Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2
Business Address SUITE 200, 1920 YONGE STREET TORONTO A6 M4S 3E2 416-847-6898
ProMIS Neurosciences Inc. (Filer) CIK: 0001374339 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41429 | Film No.: 25641149
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)